DEXCOM, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
DEXCOM, INC. (DXCM) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $16.60 million as of 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-02-12
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $16.60M.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $12.00M.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $16.70M.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $20.30M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $16.60M 10-K · filed 2026-02-12 |
| 2024-12-31 | $12.00M 10-K · filed 2025-02-18 |
| 2023-12-31 | $16.70M 10-K · filed 2024-02-08 |
| 2022-12-31 | $20.30M 10-K · filed 2023-02-09 |
| 2021-12-31 | $17.30M 10-K · filed 2022-02-14 |
| 2020-12-31 | $20.20M 10-K · filed 2021-02-11 |
| 2019-12-31 | $14.30M 10-K · filed 2020-02-13 |
| 2019-09-30 | $4.90M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $5.40M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $3.60M 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |